文献

J-GLOBAL ID：202002231801013573   整理番号：20A0116946

改良FOLFIRINOXによる全身化学療法に応答する転移性膵粘液癌に対する転換手術:症例報告

Conversion Surgery for Metastatic Pancreatic Mucinous Carcinoma Responsive to Systemic Chemotherapy with Modified FOLFIRINOX: A Case Report

著者 (13件)： Yokoyama Tadashi (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Makino Hiroshi (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Hirakata Atsushi (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Ueda Junji (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Takata Hideyuki (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Okusa Mikihiro (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Kawashima Manpei (Department of Surgery, Tama Nagayama Hospital, Nippon Medical School) ,  Tsujino Takeshi (Department of Gastroenterology, Tama Nagayama Hospital, Nippon Medical School) ,  Tsujino Takeshi (Miyuki Clinic) ,  Hosone Masaru (Department of Pathology, Tama Nagayama Hospital, Nippon Medical School) ,  Matsushita Akira (Department of Gastroenterological Surgery, Nippon Medical School) ,  Nakamura Yoshiharu (Department of Gastroenterological Surgery, Nippon Medical School) ,  Yoshida Hiroshi (Department of Gastroenterological Surgery, Nippon Medical School)
資料名： Journal of Nippon Medical School  (Journal of Nippon Medical School)
巻： 86  号： 5  ページ： 284-290(J-STAGE)  発行年： 2019年 
JST資料番号： F0887A  ISSN： 1345-4676  CODEN： JNMSF5  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 転移性膵頭部粘液癌(多発性リンパ節と骨転移を伴う)の症例を報...

シソーラス用語： *粘液癌 ,...
準シソーラス用語： *膵粘液癌 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0116946&from=J-GLOBAL&jstjournalNo=F0887A") }}

著者キーワード (3件)： 膵臓粘液癌 ,  改良されたFOLFIRINOX ,  転換手術

分類 (1件)： 消化器の腫よう  (GH04000D)

物質索引 (3件)： フルオロウラシル ,  レボホリナートカルシウム ,  塩酸イリノテカン

引用文献 (21件)：

• 1. Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardiere C, Bennouna J, Bachet JB, Khemissa-Akouz F, Pere-Verge D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M, for the Groupe Tumeurs Digestives of Unicancer and the PRODIGE Intergroup: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825.
• 2. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF: Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691-1703.
• 3. Kunzmann V, Herrmann K, Bluemel C, Kapp M, Hartlapp I, Steger U: Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer. Case Rep Oncol 2014; 7: 648-655.
• 4. Okusaka T, Ikeda M, Fukutomi A, Ioka T, Furuse J, Ohkawa S, Isayama H, Boku N: Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Sci 2014; 105: 1321-1326.
• 5. Blazer M, Wu C, Goldberg RM, Phillips G, Schmidt C, Muscarella P, Wuthrick E, Williams TM, Reardon J, Ellison EC, Bloomston M, Bekaii-Saab T: Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas. Ann Surg Oncol 2015; 22: 1153-1159.

タイトルに関連する用語 (8件)： FOLFIRINOX ,  全身化学療法 ,  応答 ,  転移性 ,  膵粘液癌 ,  転換 ,  手術 ,  症例報告